Aradigm Health platform enables access to next generation of transformative therapies—cell and gene therapies (CGTs).
Aradigm Health has raised $20.0M in total funding. The most recent round was Series A. The last funding was announced in December 2025.
Aradigm Health's investors include Andreessen Horowitz, Frist Cressey Ventures, Morgan Health.
Aradigm Health is headquartered in Bethesda, United States.
Aradigm Health platform enables access to next generation of transformative therapies—cell and gene therapies (CGTs).
Aradigm Health is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aradigm Health — Funding & Investors." VCBacked, December 9, 2025, https://www.vcbacked.co/company/aradigm-health. Accessed August 14, 2026.
VCBacked. (2025). Aradigm Health — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/aradigm-health
{{cite web |title=Aradigm Health — Funding & Investors |url=https://www.vcbacked.co/company/aradigm-health |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated